123 related articles for article (PubMed ID: 31606407)
21. Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson's disease model in rats.
Bassani TB; Gradowski RW; Zaminelli T; Barbiero JK; Santiago RM; Boschen SL; da Cunha C; Lima MM; Andreatini R; Vital MA
Brain Res; 2014 Dec; 1593():95-105. PubMed ID: 25301688
[TBL] [Abstract][Full Text] [Related]
22. Crocus sativus restores dopaminergic and noradrenergic damages induced by lead in Meriones shawi: A possible link with Parkinson's disease.
Tamegart L; Abbaoui A; Makbal R; Zroudi M; Bouizgarne B; Bouyatas MM; Gamrani H
Acta Histochem; 2019 Feb; 121(2):171-181. PubMed ID: 30573341
[TBL] [Abstract][Full Text] [Related]
23. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
[TBL] [Abstract][Full Text] [Related]
24. The neuronal basis of copper induced modulation of anxiety state in rat.
Abbaoui A; E L Hiba O; Gamrani H
Acta Histochem; 2017 Jan; 119(1):10-17. PubMed ID: 27863709
[TBL] [Abstract][Full Text] [Related]
25. Mesocortical Dopamine Phenotypes in Mice Lacking the Sonic Hedgehog Receptor Cdon.
Verwey M; Grant A; Meti N; Adye-White L; Torres-Berrío A; Rioux V; Lévesque M; Charron F; Flores C
eNeuro; 2016; 3(3):. PubMed ID: 27419218
[TBL] [Abstract][Full Text] [Related]
26. Balance alterations and reduction of pedunculopontine cholinergic neurons in early stages of parkinsonism in middle-aged rats.
Dos Santos TFO; de R Santos E; Bispo JMM; de Souza MF; de Gois AM; Lins LCRF; Silva RH; Ribeiro AM; Marchioro M; Dos Santos JR
Exp Gerontol; 2021 Mar; 145():111198. PubMed ID: 33310153
[TBL] [Abstract][Full Text] [Related]
27. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
[TBL] [Abstract][Full Text] [Related]
28. Differential Effects of LPS and 6-OHDA on Microglia's Morphology in Rats: Implications for Inflammatory Model of Parkinson's Disease.
Parra I; Martínez I; Ramírez-García G; Tizabi Y; Mendieta L
Neurotox Res; 2020 Jan; 37(1):1-11. PubMed ID: 31478124
[TBL] [Abstract][Full Text] [Related]
29. Alteration of dopaminergic innervation and voluntary movements after long period of thirst in a semi-desert rodent, Meriones shawi: behavioral and immunohistochemical studies.
Elgot A; El Hiba O; Gamrani H
C R Biol; 2012 Jul; 335(7):463-71. PubMed ID: 22847013
[TBL] [Abstract][Full Text] [Related]
30. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
[TBL] [Abstract][Full Text] [Related]
31. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA
Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943
[TBL] [Abstract][Full Text] [Related]
32. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
[TBL] [Abstract][Full Text] [Related]
33. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
[TBL] [Abstract][Full Text] [Related]
34. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.
Santos JR; Cunha JA; Dierschnabel AL; Campêlo CL; Leão AH; Silva AF; Engelberth RC; Izídio GS; Cavalcante JS; Abílio VC; Ribeiro AM; Silva RH
Behav Brain Res; 2013 Sep; 253():68-77. PubMed ID: 23831411
[TBL] [Abstract][Full Text] [Related]
35. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area.
Xavier LL; Viola GG; Ferraz AC; Da Cunha C; Deonizio JM; Netto CA; Achaval M
Brain Res Brain Res Protoc; 2005 Dec; 16(1-3):58-64. PubMed ID: 16310404
[TBL] [Abstract][Full Text] [Related]
36. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area.
Krashia P; Martini A; Nobili A; Aversa D; D'Amelio M; Berretta N; Guatteo E; Mercuri NB
Eur J Neurosci; 2017 Jan; 45(1):92-105. PubMed ID: 27519559
[TBL] [Abstract][Full Text] [Related]
37. Impact of prenatal nicotine on the structure of midbrain dopamine regions in the rat.
Omelchenko N; Roy P; Balcita-Pedicino JJ; Poloyac S; Sesack SR
Brain Struct Funct; 2016 May; 221(4):1939-53. PubMed ID: 25716298
[TBL] [Abstract][Full Text] [Related]
38. Effects of early and late neonatal bromocriptine treatment on hypothalamic neuropeptides, dopaminergic reward system and behavior of adult rats.
Carvalho JC; Lisboa PC; de Oliveira E; Peixoto-Silva N; Pinheiro CR; Fraga MC; Claudio-Neto S; Franci CR; Manhães AC; Moura EG
Neuroscience; 2016 Jun; 325():175-87. PubMed ID: 27038750
[TBL] [Abstract][Full Text] [Related]
39. Programming of Dopaminergic Neurons by Neonatal Sex Hormone Exposure: Effects on Dopamine Content and Tyrosine Hydroxylase Expression in Adult Male Rats.
Espinosa P; Silva RA; Sanguinetti NK; Venegas FC; Riquelme R; González LF; Cruz G; Renard GM; Moya PR; Sotomayor-Zárate R
Neural Plast; 2016; 2016():4569785. PubMed ID: 26904299
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical sleep deprivation modulates tyrosine hydroxylase expression in the nigrostriatal pathway and attenuates motor deficits induced by dopaminergic depletion.
Lima MM; Andersen ML; Reksidler AB; Ferraz AC; Vital MA; Tufik S
CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):359-68. PubMed ID: 22483308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
